These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35982742)

  • 1. Long-term results of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and chronic kidney disease.
    Michlicka-Kłyś W; Kalarus Z; Podolecki T; Mitręga K; Streb W
    Postepy Kardiol Interwencyjnej; 2022 Mar; 18(1):43-49. PubMed ID: 35982742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.
    Brockmeyer M; Wolff G; Krieger T; Lin Y; Karathanos A; Afzal S; Zeus T; Westenfeld R; Polzin A; Heinen Y; Perings S; Kelm M; Schulze V
    Acta Cardiol; 2020 Aug; 75(4):312-320. PubMed ID: 30983505
    [No Abstract]   [Full Text] [Related]  

  • 3. Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long-term follow-up.
    López-Tejero S; Antúnez-Muiños P; Fraile-Gómez P; Sousa GB; Rodríguez-Collado J; Herrero-Garibi J; Blanco-Fernández F; Diego-Nieto A; Delgado-Lapeira GC; Del Villar-Moro MCP; Martín-Moreiras J; Sánchez-Fernández PL; Cruz-González I
    Catheter Cardiovasc Interv; 2024 Feb; 103(3):499-510. PubMed ID: 38168895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.
    Flores-Umanzor E; Asghar A; Cepas-Guillén PL; Farrell A; Keshvara R; Alvarez-Rodriguez L; Osten M; Freixa X; Horlick E; Abrahamyan L
    Clin Res Cardiol; 2023 Dec; ():. PubMed ID: 38112741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
    Besola L; Gregori D; Fiocco A; Colli A
    Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data.
    Litwinowicz R; Filip G; Sobczyk D; Lakkireddy D; Vuddanda VLK; Bartuś M; Kapelak B; Bartuś K
    Postepy Kardiol Interwencyjnej; 2020 Mar; 16(1):89-96. PubMed ID: 32368241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous devices for left atrial appendage occlusion: A contemporary review.
    Moussa Pacha H; Al-Khadra Y; Soud M; Darmoch F; Moussa Pacha A; Alraies MC
    World J Cardiol; 2019 Feb; 11(2):57-70. PubMed ID: 30820276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end-stage renal disease on hemodialysis: A single center experience.
    Xipell M; Flores-Umanzor E; Ojeda R; Arias M; Cepas-Guillén PL; Regueiro A; Freixa X; Cases A; Maduell F
    Artif Organs; 2020 May; 44(5):513-521. PubMed ID: 31715006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update.
    Chen S; Chun KRJ; Ling Z; Liu S; Zhu L; Wang J; Schratter A; Acou WJ; Kiuchi MG; Yin Y; Schmidt B
    J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34208117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
    Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Kefer J; Tzikas A; Freixa X; Shakir S; Gafoor S; Nielsen-Kudsk JE; Berti S; Santoro G; Aminian A; Landmesser U; Nietlispach F; Ibrahim R; Danna PL; Benit E; Budts W; Stammen F; De Potter T; Tichelbäcker T; Gloekler S; Kanagaratnam P; Costa M; Cruz-Gonzalez I; Sievert H; Schillinger W; Park JW; Meier B; Omran H
    Int J Cardiol; 2016 Mar; 207():335-40. PubMed ID: 26820363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real-world experience from a tertiary care hospital.
    Margonato D; Preda A; Ingallina G; Rizza V; Fierro N; Radinovic A; Ancona F; Patti G; Agricola E; Bella PD; Mazzone P
    J Arrhythm; 2023 Jun; 39(3):395-404. PubMed ID: 37324751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade later: long-term results of the first percutaneous epicardial closure of the left atrial appendage using the LARIAT device.
    Burysz M; Malec-Litwinowicz M; Batko J; Litwinowicz R; Kowalewski M; Kapelak BA; Bartus K
    Kardiochir Torakochirurgia Pol; 2023 Dec; 20(4):215-219. PubMed ID: 38283554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous left atrial appendage occlusion: A South African experience.
    Dippenaar AP; Saaiman JA; Brink PA; Heradien MJ; Van der Bijl P
    S Afr Med J; 2022 Apr; 112(4):268-272. PubMed ID: 35587805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy".
    Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L
    Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.